Company Profile

ReliaGene Technologies Inc (AKA: GenTest Laboratories, Inc)
Profile last edited on: 2/24/11      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1990
First Award
1992
Latest Award
2003
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

5525 Mounes Street Suite 101
New Orleans, LA 70123
   (504) 734-9700
   info@reliagene.com
   N/A
Location: Single
Congr. District: 01
County: Jefferson Parish

Public Profile

In October 2007, ReliaGene Technologies Inc, (formerly known as GenTest), was acquired by Orchid Cellmark Inc, which is also an SBIR firm. ReliaGene is a full service DNA testing laboratory. The firm has extensive experience in analyzing forensic and paternity cases and providing expert witness testimony. ReliaGene Technologies, Inc. specializes in human genetic identification for forensic and parentage testing applications. ReliaGene has grown rapidly by consistently providing accurate DNA test results for use in both civil and criminal courts of law, and through an ongoing commitment to technological advancement and personalized customer service. ReliaGene has successfully produced genetic profiles of well over 400,000 biological samples and is one of the few laboratories to offer a full range of DNA testing systems including: polymerase chain reaction (PCR), restriction fragment length polymorphism (RFLP), mitochondrial DNA sequencing (mtDNA), and Y-chromosome DNA testing (Y-STR). Therefore, ReliaGene has the ability to empower its international client-base with the utmost in available technology and testing options.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
50-74
Revenue Range
5M-7.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2003 2 NIH $849,925
Project Title: Dimorphic ALU Repeats-Application in Identity Testing
1992 1 NIH $49,996
Project Title: Evaluation of galactosyltransferase II as a tumor marker

Key People / Management

Company News

There are no news available.